10-Year outcome of descemet stripping only in a patient with Fuchs endothelial dystrophy: a case report.

IF 2.3 Q2 OPHTHALMOLOGY
Therapeutic Advances in Ophthalmology Pub Date : 2025-08-30 eCollection Date: 2025-01-01 DOI:10.1177/25158414251359583
Fuad Moayed, Friedrich Anton Steindor, Zaira Eleni Armeni, Markus Kohlhaas, Gerd Geerling
{"title":"10-Year outcome of descemet stripping only in a patient with Fuchs endothelial dystrophy: a case report.","authors":"Fuad Moayed, Friedrich Anton Steindor, Zaira Eleni Armeni, Markus Kohlhaas, Gerd Geerling","doi":"10.1177/25158414251359583","DOIUrl":null,"url":null,"abstract":"<p><p>In recent years, descemet stripping only (DSO) has emerged as an alternative to descemet membrane endothelial keratoplasty (DMEK) in certain patients with Fuchs endothelial dystrophy (FED). We herein report the 10-year follow-up of a 77-year-old male patient after bilateral DSO. The patient initially underwent DSO on the right eye for circumscribed cornea guttata. Three weeks after DSO, the best-corrected visual acuity (BCVA) already increased from 0.5 logarithm of the Minimum Angle of Resolution (logMAR) [Endothelial Cell Density (ECD) 1667/mm<sup>2</sup>, Central Corneal Thickness (CCT) 583 µm] to 0.2 logMAR, and further improved to 0 logMAR 1 year after surgery (ECD 2213/mm<sup>2</sup>, CCT 567 µm). This excellent visual acuity remained stable over the following 5 years (ECD 1696/mm<sup>2</sup>, CCT 568 µm). Five years after the successful surgery on the right eye, DSO was also performed on the left eye by the same surgeon as FED progressed, with BCVA dropping to 0.5 logMAR (ECD unmeasurable, CCT 703 µm). However, this time, the treatment did not improve vision. Consequently, a DMEK was performed 7 months after DSO, which increased the BCVA to 0.1 logMAR. Ten years after successful DSO of the right eye, corneal guttata were observed, indicating de novo formation of a descemet membrane, and vision deteriorated again to 0.2 logMAR (ECD not measurable, CCT 641 µm). DMEK was also performed on the right eye ten years after successful DSO, which improved vision to 0.2 logMAR at one-year follow-up. This case suggests that DSO may be a temporary alternative to DMEK in FED, potentially providing excellent visual gain and good central endothelial cell density for nearly ten years. However, it may still fail due to long-term progression of the disease. It also highlights that the outcome may be limited by individual factors. Therefore, it is crucial to educate the patient about the limitations of DSO, both in short and long term. Nevertheless, if DSO fails, endothelial keratoplasty can still be successfully performed.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"17 ","pages":"25158414251359583"},"PeriodicalIF":2.3000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12398654/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/25158414251359583","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In recent years, descemet stripping only (DSO) has emerged as an alternative to descemet membrane endothelial keratoplasty (DMEK) in certain patients with Fuchs endothelial dystrophy (FED). We herein report the 10-year follow-up of a 77-year-old male patient after bilateral DSO. The patient initially underwent DSO on the right eye for circumscribed cornea guttata. Three weeks after DSO, the best-corrected visual acuity (BCVA) already increased from 0.5 logarithm of the Minimum Angle of Resolution (logMAR) [Endothelial Cell Density (ECD) 1667/mm2, Central Corneal Thickness (CCT) 583 µm] to 0.2 logMAR, and further improved to 0 logMAR 1 year after surgery (ECD 2213/mm2, CCT 567 µm). This excellent visual acuity remained stable over the following 5 years (ECD 1696/mm2, CCT 568 µm). Five years after the successful surgery on the right eye, DSO was also performed on the left eye by the same surgeon as FED progressed, with BCVA dropping to 0.5 logMAR (ECD unmeasurable, CCT 703 µm). However, this time, the treatment did not improve vision. Consequently, a DMEK was performed 7 months after DSO, which increased the BCVA to 0.1 logMAR. Ten years after successful DSO of the right eye, corneal guttata were observed, indicating de novo formation of a descemet membrane, and vision deteriorated again to 0.2 logMAR (ECD not measurable, CCT 641 µm). DMEK was also performed on the right eye ten years after successful DSO, which improved vision to 0.2 logMAR at one-year follow-up. This case suggests that DSO may be a temporary alternative to DMEK in FED, potentially providing excellent visual gain and good central endothelial cell density for nearly ten years. However, it may still fail due to long-term progression of the disease. It also highlights that the outcome may be limited by individual factors. Therefore, it is crucial to educate the patient about the limitations of DSO, both in short and long term. Nevertheless, if DSO fails, endothelial keratoplasty can still be successfully performed.

Abstract Image

Abstract Image

Abstract Image

仅对1例Fuchs内皮营养不良患者进行血管剥离治疗的10年预后:1例报告。
近年来,在某些患有Fuchs内皮营养不良(FED)的患者中,仅角膜内皮剥离(DSO)已成为角膜内皮膜内皮角膜移植术(DMEK)的替代方法。我们在此报告一位77岁男性患者在双侧DSO后的10年随访。患者最初在右眼接受了DSO手术,以治疗边缘性角膜裂。DSO术后3周,最佳矫正视力(BCVA)已经从0.5对数最小分辨角(logMAR)[内皮细胞密度(ECD) 1667/mm2,角膜中央厚度(CCT) 583µm]增加到0.2对数最小分辨角(logMAR),并在术后1年进一步提高到0对数最小分辨角(ECD 2213/mm2, CCT 567µm)。这种优异的视力在接下来的5年里保持稳定(ECD 1696/mm2, CCT 568µm)。右眼手术成功5年后,同一位外科医生在左眼也进行了DSO手术,随着FED的进展,BCVA降至0.5 logMAR (ECD无法测量,CCT 703µm)。然而,这一次,治疗并没有改善视力。因此,在DSO后7个月进行DMEK,使BCVA增加到0.1 logMAR。右眼DSO成功后10年,观察到角膜凹痕,表明下膜重新形成,视力再次恶化至0.2 logMAR (ECD不可测量,CCT 641µm)。在DSO成功后10年也对右眼进行DMEK,在1年随访时视力提高到0.2 logMAR。该病例提示,DSO可能是FED患者DMEK的临时替代品,可能在近十年的时间里提供出色的视觉增益和良好的中心内皮细胞密度。然而,由于疾病的长期进展,它仍然可能失败。它还强调,结果可能受到个人因素的限制。因此,教育患者DSO的局限性是至关重要的,无论是短期的还是长期的。然而,如果DSO失败,内皮角膜移植术仍然可以成功进行。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.50
自引率
0.00%
发文量
44
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信